Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: Presentation and response to treatment

被引:5
|
作者
Aversa, S. M. L. [1 ]
Stragliotto, S. [1 ]
Marino, D. [1 ]
Calabrese, F. [3 ]
Rigotti, P. [4 ]
Marchini, F. [4 ]
Gambino, A. [5 ]
Feltrin, G. [5 ]
Boso, C. [2 ]
Canova, F. [1 ]
Solda, C. [1 ]
Mazzarotto, R. [2 ]
Burra, P. [6 ]
机构
[1] IRCCS, Div Med Oncol, Ist Oncol Veneto, IT-35128 Padua, Italy
[2] IRCCS, Dept Radiotherapy, Ist Oncol Veneto, IT-35128 Padua, Italy
[3] Univ Padua, Dept Med Sci & Special Therapies, Padua, Italy
[4] Univ Padua, Kidney & Pancreas Transplantat Unit, Dept Med & Surg Sci, Padua, Italy
[5] Univ Padua, Dept Cardiothorac Sci, Padua, Italy
[6] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy
关键词
post-transplant lymphoproliferative disorders; solid organ transplantation; weekly chemotherapy;
D O I
10.1159/000155234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-transplant lymphoproliferative disorders (PTLD) is a serious complication after solid organ transplantation. Reduction of immunosuppression (RI) alone is not able to control the disease. We report a prospective analysis of 30 patients with PTLD after heart or kidney transplantation. Only 5 of 30 patients, treated solely with RI, obtained a complete response. Five patients were treated heterogeneously; in the remaining 20, the efficacy and safety of a weekly anthracycline-based chemotherapy were assessed. Sixteen patients obtained a complete remission. One death was related to treatment. With a median follow-up of 36 months, 3-year overall survival was 63.3% and 57% for the entire group and the chemotherapy-treated group, respectively. Moreover, 4 second neoplasms were observed in the chemotherapeutic group. In this study, we demonstrated that most PTLD need other treatment than RI and a weekly regimen is manageable and has a favourable impact on long-term survival. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:36 / 46
页数:11
相关论文
共 50 条
  • [31] Treatment and outcomes of patients with post-transplant lymphoproliferative disorder: a single centre experience
    Ortiz, C. de Ramon
    Samii, K.
    Avram, A.
    Mamez, A. C.
    Masouridi-Levrat, S.
    Chalandon, Y.
    Beauverd, Y.
    SWISS MEDICAL WEEKLY, 2022, 152 : 39S - 40S
  • [32] Post-transplant Lymphoproliferative Disorders in Liver Transplanted Patients: A Single-centre Experience
    Marino, D.
    Burra, P.
    Boccagni, P.
    Calabrese, F.
    Canova, F.
    Trentin, C.
    Boso, C.
    Solda, C.
    Angeli, P.
    Aversa, S. M. L.
    ANTICANCER RESEARCH, 2010, 30 (06) : 2383 - 2391
  • [33] Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation
    Bacha, Mohamed Mongi
    Abderrahim, Ezzeddine
    Ounissi, Mondher
    Chaouech, Dalel
    Cherif, Mejda
    Turki, Sami
    Rajhi, Hatem
    Znaidi, Nadia
    Bahloul, Abdessalem
    Trabelsi, Sonia
    Khaled, Samira
    Ben Abdallah, Taieb
    Ben Maiz, Hedi
    Kheder, Adel
    NEPHROLOGIE & THERAPEUTIQUE, 2011, 7 (06): : 488 - 493
  • [34] Post-transplant lymphoproliferative disease after pediatric kidney transplant
    Fulchiero, Rosanna
    Amaral, Sandra
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [35] Post transplantation lymphoproliferative disorders in heart and kidney/pancreas transplant patients: A single-center experience
    Stragliotto, Silvia
    Marino, Dario
    Stefani, Micaela
    Crivellari, Gino
    Aversa, Savina
    ANNALS OF ONCOLOGY, 2007, 18 : 63 - 63
  • [36] Post-transplant lymphoproliferative disease after liver transplantation
    Ignacio Herrero, Jose
    Panizo, Carlos
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (02) : 131 - 131
  • [37] Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation
    Bakker, Nicolaas A.
    van Imhoff, Gustaaf W.
    Verschuuren, Erik A. M.
    van Son, Willem J.
    TRANSPLANT INTERNATIONAL, 2007, 20 (03) : 207 - 218
  • [38] Epistaxis in a kidney transplant recipient: An uncommon presentation of post-transplant lymphoproliferative disease
    Yap, Desmond Y. H.
    Chan, Gary C. W.
    Mok, Maggie M. Y.
    Chan, Tak Mao
    NEPHROLOGY, 2013, 18 (07) : 531 - 531
  • [39] Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients
    Zierhut, Henriette
    Kanzelmeyer, Nele
    Buescher, Anja
    Hoecker, Britta
    Mauz-Korholz, Christine
    Tonshoff, Burkhard
    Metzler, Markus
    Pohl, Martin
    Pape, Lars
    Maecker-Kolhoff, Britta
    PEDIATRIC TRANSPLANTATION, 2021, 25 (06)
  • [40] Diagnosis, Treatment and Outcome of Hodgkin Like Post-Transplant Lymphoproliferative Disease after Pediatric Heart Transplantation: A Single Center Experience
    Behnke-Hall, K.
    Wagner, H. -J.
    Bauer, J.
    Thul, J.
    Mandy, H.
    Reiter, A.
    Schranz, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S170 - S171